Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:934-940

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burke, A. P.
Right arrow Articles by Virmani, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burke, A. P.
Right arrow Articles by Virmani, R.
Related Collections
Right arrow Chronic ischemic heart disease
Right arrow Risk Factors
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2001;103:934.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Healed Plaque Ruptures and Sudden Coronary Death

Evidence That Subclinical Rupture Has a Role in Plaque Progression

Allen P. Burke, MD; Frank D. Kolodgie, PhD; Andrew Farb, MD; Deena K. Weber, BS; Gray T. Malcom, PhD; John Smialek, MD; Renu Virmani, MD

From the Department of Cardiovascular Pathology (A.P.B., F.D.K., A.F., D.K.W., R.V.), Armed Forces Institute of Pathology, Washington, DC; Louisiana State University (G.T.M.), New Orleans; and the University of Maryland (J.S.), Baltimore.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Subclinical episodes of plaque disruption followed by healing are considered a mechanism of increased plaque burden. Detailed pathological studies of healed ruptures, however, are lacking.

Methods and Results—We identified acute and healed ruptures from 142 men who died of sudden coronary death and performed morphometric measurements of plaque burden, luminal stenosis, and smooth muscle cell phenotype. Healed ruptures were found in 61% of hearts and were associated with healed myocardial infarction, increased heart weight, dyslipidemia, and diabetes. Multiple healed rupture sites with layering were frequently found in segments with acute and healed rupture; the percent area luminal narrowing increased with increased numbers of healed sites of previous rupture. The underlying percent luminal narrowing for acute ruptures (mean 79±15%) exceeded that for healed ruptures (mean 66±14%, P=0.0001), and the area within the internal elastic lamina was significantly less in healed ruptures than in acute ruptures, when segments were grouped by distance from the ostium. Healed ruptures favored the accumulation of immature smooth muscle cells at repair sites, with a cellular proliferation index of 0.40±0.09%, significantly higher than the index at the sites of rupture (P=0.008).

Conclusions—These data provide evidence that silent plaque rupture is a form of wound healing that results in increased percent stenosis. Healed ruptures occur in arteries with less cross-sectional area luminal narrowing than acute ruptures and are a frequent finding in men who die suddenly with severe coronary atherosclerosis.


Key Words: plaque • death, sudden


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Plaque rupture is the most common lesion underlying acute coronary syndromes.1 2 Pathological studies suggest, however, that some plaques may rupture silently without causing symptoms.3 Healed ruptures in the coronary vascular bed are readily detected microscopically by identification of breaks in the fibrous cap with a surrounding repair reaction.4 The matrix within the healed fibrous cap consists of a proteoglycan-rich mass or a collagen-rich scar, depending on the healing phase. The prevalence of silent ruptures in the clinical population is unknown, because imaging techniques to detect sites of previous plaque rupture are currently unavailable.

Although stenosis is easily identified by angiography, very few data exist to explain how plaques narrow. It is speculated that repeated fibrous cap rupture and thrombosis can incite plaque progression and/or tissue contraction in the absence of clinical ischemic events. Therefore, an understanding of the pathology of healed ruptures is of critical clinical importance. The purpose of this study was to determine the incidence and morphological characteristics, as well as the relationship to traditional risk factors, of healed plaque ruptures in a series of sudden cardiac death.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Case Selection
Hearts (n=142) from male patients were prospectively examined in consultation with and under the direct supervision of the Office of the Chief Medical Examiner in the State of Maryland. Criteria for entry into the study included sudden unexpected coronary death, male sex, and exclusion of noncoronary causes of death after a full forensic autopsy. Coronary deaths were defined as natural deaths without extracardiac cause of death in which >=1 epicardial coronary artery had >=75% cross-sectional area lumen narrowed by atherosclerotic plaque or plaque with superimposed thrombus.5 One hundred thirteen of these cases were published previously without data on healed plaque ruptures.6 7

Classification of Sudden Deaths
Sudden deaths were initially classified by the presumed mechanism of death: acute thrombus due to acute plaque rupture, acute thrombus due to acute plaque erosion, stable plaque with healed infarct in the absence of an acute thrombus, and stable plaque (>=75% cross-sectional area luminal narrowing) without evidence of infarction.6 8

Identification of Healed Sites
Coronary arteries were studied as previously described.6 Any area of cross-sectional luminal narrowing grossly estimated at >=50% was submitted for histological analysis. All acute ruptures and any section that suggested the possibility of previous rupture on the basis of Movat pentachrome staining (healed sites recognized by brilliant blue-green color) were confirmed by picrosirius red staining and polarization microscopy.4 When viewed under polarized light, this special stain highlights collagen types III and I differentially, allowing visualization of interruptions in the fibrous cap. Healed sites consisted of breaks in collagen type I (yellow-red birefringence) overlying a necrotic core with superimposed layer of collagen type III (green birefringence) (Figure 1Down).



View larger version (114K):
[in this window]
[in a new window]
 
Figure 1. Healed plaque rupture. A, Areas of intraintimal lipid-rich core with hemorrhage and cholesterol clefts. B, Higher magnification of looser SMC formation within collagenous proteoglycan-rich neointima showing clear demarcation, with more fibrous regions of old plaque to right. C and D, Layers of collagen by Sirius red staining. C, Note area of dense, dark-red collagen surrounding lipid hemorrhagic cores seen in corresponding view in A. D, Image taken with polarized light. Dense collagen (type 1) that forms fibrous cap is lighter reddish-yellow and is disrupted (arrow), with newer greenish type III collagen on right and above rupture site. A and B, Movat pentachrome.

Risk Factor Analysis
Evaluation of traditional risk factors was performed on postmortem blood samples as previously described.6 Total cholesterol, HDL cholesterol, and cigarette smoking (estimated by serum thiocyanate >90 µmol/L) were determined by serum analysis, and percent glycohemoglobin, for estimation of glucose intolerance, was determined by analysis of red blood cells. Hypertension was determined by evaluation of renal vasculature and history.9 The association between risk factors and the presence of acute and healed plaque ruptures was determined by multivariate analysis (logistic regression with model coefficients, Statview software, SAS Institute) using age, glycohemoglobin, total cholesterol, HDL cholesterol, and body mass index as continuous variables and hypertension and cigarette smoking as nominal variables.

Morphometric Analysis of Healed and Acute Ruptures
The right, left anterior descending, and left circumflex coronary arteries were divided into proximal and middle distal regions. The proximal regions consisted of the first 3 cm for the right coronary, before the first diagonal branch for the left anterior descending, and the obtuse marginal for the left circumflex artery. Middle segments were between the first and second diagonals for the left anterior descending, between left obtuse marginal 1 and left obtuse marginal 2 for the circumflex, and beyond 3 cm of the right coronary artery to the right marginal branch. The arteries were grouped by distance from the ostium to compare internal elastic lamina (IEL) areas between acute and healed ruptures at proximal, middle, and distal regions. The areas within the external elastic lamina, IEL, and lumen were measured on coronary sections by use of imaging software (IP Laboratory, Scanalytics, Inc). In the case of multiple ruptures in a single section, only the most superficial rupture site with the acute thrombus or healed rupture repair site was measured. The percent stenosis was derived from the formula (1-lumen area/IEL area)x100. In cases with acute plaque rupture, the area of the thrombus was not included for the calculation of percent stenosis.

Immunohistochemistry
Cell populations were identified by use of mouse monoclonal antibodies against human muscle {alpha}-actin (1A4, Sigma Chemical Co, dilution 1:4000), macrophages (KP-1, Dako, dilution 1:50), and the T-cell marker (CD45RO, Dako, dilution 1:400). Smooth muscle maturation markers included calponin (Dako, 1:200) and smoothelin (Monosan, 1:10). To identify proliferating cells, tissue sections were stained with the monoclonal MIB-1 antibody (Ki-67, ImmunoTech, 1:500 dilution).

Analysis of immunohistochemistry for cell type and markers of smooth muscle cell (SMC) maturation were performed with color-image software (Bioquant). The most recent or superficial healed rupture site was measured in cases of multiple healed ruptures. The number of Ki-67–positive cells per section was counted manually at x400 magnification, and the percentage of positive Ki-67 cells in healed repair and acute rupture sites was calculated.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Patient Demographics and Presumed Mechanism of Death
The mean age of the 142 men was 51±11 years. There were 38 blacks and 104 whites. One hundred thirty men died without a previous history of heart disease. There was a history of heart disease in 12 cases. These consisted of recent angioplasty for unstable angina (n=1), congestive heart failure (n=2), left ventricular hypertrophy diagnosed by ECG (n=1), and a vague history of "heart problems" that were not further clarified (n=8). Thirteen hypertensive patients were on antihypertensive medications, including ACE inhibitors (n=5), calcium channel blockers (n=4), ß-blockers (n=4), and diuretics (n=5). Ten patients were being treated for diabetes with insulin or oral hypoglycemic medication, and 3 patients were taking statin drugs.

The mechanism of death was presumed to be acute plaque rupture with acute thrombus in 44 men (mean age 49±10 years), acute plaque erosion with acute thrombus in 23 men (mean age 45±8 years), stable plaque with healed infarct in 41 men (mean age 53±11 years, P=0.004 versus eroded plaque, Student’s t test), and stable plaque without myocardial infarct in 34 men (mean age 54±12 years, P=0.003 versus eroded plaque and P=0.04 versus plaque rupture).

Healed Ruptures and Culprit Plaque and Healed Infarcts
There were a total of 189 healed rupture sites, 22 of which (12%) resulted in total coronary occlusion. One or more healed ruptures not underlying an acute rupture site were present in 86 of 142 hearts (61% of total). Healed ruptures were especially frequent in hearts with acute plaque rupture (75% of cases) and hearts with stable plaque and healed myocardial infarction (80% of cases, Table 1Down). In hearts with stable culprit plaques, those with healed myocardial infarcts were more likely to have >=1 healed ruptures than those without healed myocardial infarcts (80% versus 53%, P=0.01, Fisher’s exact test), and the mean number of healed ruptures was greater (2.0±1.4 versus 1.1±1.4, P=0.016, Table 1Down, Student’s t test).


View this table:
[in this window]
[in a new window]
 
Table 1. Mean Healed Ruptures by Presumed Mechanism of Death

Evidence of Multiple Healed Previous Rupture Sites in Acute Rupture and at Healed Rupture Sites
Of the 44 acute ruptures, Sirius red staining demonstrated evidence of healed previous rupture in 33. Of these, 9 showed 1 healed previous rupture site, 9 showed 2 healed previous rupture sites, 9 showed 3 healed previous rupture sites, and 6 showed 4 healed previous rupture sites. Only 11 acute rupture sites overlay large necrotic cores filled with hemorrhage and little collagen deposition. Acute ruptures occurring at sites of >=3 healed previous rupture sites demonstrated greater underlying luminal narrowing (94±4%) than those without healed previous rupture (74±12%, P=0.001, Student’s t test). Of the 189 healed ruptures, 57 (30%) demonstrated only 1 healed rupture site, 64 (34%) showed 2 (Figure 2Down), 60 (32%) 3, and 8 (4%) 4.



View larger version (64K):
[in this window]
[in a new window]
 
Figure 2. Multiple healed rupture sites. A, Cross section of epicardial artery (Movat pentachrome) with thick fibrous cap overlying hemorrhagic necrotic core. Sirius red stain (B) of a section {approx}0.1 mm distal shows dense collagen overlying first healed rupture (1) and a second necrotic core (2). With polarization (C), more recent rupture site is identified as a strand of collagen (arrow). More recent collagen is green, near lumen, and older collagen more orange/yellow, toward base of plaque.

Morphometric Comparison of Acute and Healed Plaque Ruptures
The mean percent cross-sectional area luminal narrowing increased with the number of healed rupture sites (Figure 3Down) and was consistently greater in acute versus healed ruptures. Acute ruptures occurred in arteries with a larger IEL compared with healed ruptures in all 3 locations: proximal, middle, and distal segments (Figure 4Down).



View larger version (49K):
[in this window]
[in a new window]
 
Figure 3. With increased numbers of healed rupture sites, there is an increase in mean percent luminal narrowing in both acute and healed rupture (stable plaque) sites. A, At sites of healed rupture (stable plaque) without acute rupture, percent luminal narrowing increased with increasing numbers of healed rupture sites (P=0.0001, ANOVA, Fisher’s protected least significant difference post hoc test). B, Likewise, at sites of acute rupture, percent luminal narrowing increased with increasing numbers of previous healed rupture sites (P=0.007, ANOVA, Fisher’s protected least significant difference test). Thrombus was not measured to derive percent narrowing.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 4. When grouped by distance from ostium, acute ruptures occurred in arteries with greater IEL area compared with healed ruptures. This figure compares IEL area in acute and healed ruptures by distance from coronary ostium (proximal, middle, and distal, as defined in Methods). Ruptures were grouped by site to adjust for obvious effect of distance from ostium. Difference in IEL between acute rupture and healed plaque rupture was significant in all groups: distal (P=0.006), mid (P=0.03), and proximal (P=0.02) arteries.

Cell Proliferation and Muscle Differentiation
The mean cell proliferation index in the healed rupture sites was 0.40±0.09%, compared with 0.16±0.04% in areas of acute rupture (P=0.008, Student’s t test) (Figure 5Down). Evidence of cell proliferation was found in healed rupture sites in 76% of cases studied, but in only 1 case of acute rupture. The mean percent area of {alpha}-actin was 19.9±3.7% in areas of healed rupture, versus 2.1±1.3% for calponin (Figure 6Down). The mean % {alpha}-actin area/% calponin staining in areas of healed rupture was 15.7±8.4%. There was no evidence of smoothelin expression in healed rupture sites, despite staining within the media as an internal control.



View larger version (116K):
[in this window]
[in a new window]
 
Figure 5. Cellular proliferation in healed rupture sites. A, Hematoxylin-eosin–stained section of healed rupture site outlined by arrows. Lipid core is above healed rupture site. * indicates junction of healed site with relatively normal neointima. Adjoining section was stained for Ki-67, a proliferation marker (B); box in A represents healed site. Scattered SMCs with nuclear staining (arrows) are seen in brown; nonreactive nuclei appear blue.



View larger version (66K):
[in this window]
[in a new window]
 
Figure 6. Healed rupture site, SMC immunophenotype. A, Movat pentachrome stain demonstrates matrix-rich area of healed rupture site (arrows). B, {alpha}-Actin stain, with weaker staining for calponin (C).

Healed Ruptures and Risk Factors
Elevated total cholesterol and total/HDL cholesterol were associated with the presence of 1 or 2 healed ruptures, and elevated cholesterol, total/HDL cholesterol, glycohemoglobin, advanced age, and increased body mass index were associated with >=3 healed ruptures (Table 2Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Multivariate Analysis (Logistic Regression), Association of Risk Factors and Healed Ruptures

Healed Ruptures and Heart Weight
Heart weight was increased in men who died with healed infarcts and stable plaque (mean 530±116 g) compared with plaque erosion (464±105 g, P=0.03) or stable plaque without healed infarction (460±98, P=0.008, Student’s t test). As the numbers of healed ruptures increased, so did heart weight (468±116 g, no healed ruptures; 498±118 g, 1 to 2 healed ruptures; 558±114 g, >2 healed ruptures; none versus 1 to 2 healed ruptures, P=0.03, and none versus >2 healed ruptures, P=0.002). When hypertensive men were excluded, there was a greater association between heart weight and healed ruptures (431±73 g, no healed ruptures; 493±113 g, 1 to 2 healed ruptures; 554±112 g, >2 healed ruptures; P=0.0001, none versus >2 healed ruptures).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Plaque rupture occurs in atherosclerotic plaques with a thin fibrous cap overlying a necrotic core that is rich in lipids,10 and it is the most important mechanism of plaque instability that leads to coronary thrombosis.1 11 12 Angiographic studies have firmly established the association of thrombosis as an important mechanism of unstable angina and acute myocardial infarction.13 Not all severely narrowed segments identified by angiography, however, have evidence of previous acute thrombosis, and a few angiographic studies that have demonstrated plaque progression in the short term have suggested that thrombosis is the cause. Autopsy studies have suggested that coronary thrombosis may occur in the absence of cardiac symptoms, resulting in progression of atherosclerosis.3 14 Our observations in sudden unexpected death demonstrate that patients who died with acute plaque rupture and those with healed myocardial infarction had the highest frequency of healed plaque ruptures (75% and 80%, respectively), whereas those who died with plaque erosions had the fewest (9%) and those who died with stable plaques had an intermediate incidence (53%).

A retrospective analysis of the mechanisms of progressive luminal narrowing based on morphology at a single time point has its limitations. Nevertheless, the present study supports the hypothesis of plaque rupture as a mechanism of increased luminal narrowing. First, evidence of previous plaque rupture was common in arteries with acute rupture. Indeed, an acute rupture overlying a single, large, lipid-rich pool without evidence of previous collagen layering was the exception in these culprit plaques. Second, acute ruptures overlying healed ruptures were more narrowed than de novo ruptures, suggesting that repetitive injury may cause plaque enlargement. Third, there was a low but significantly increased rate of cell proliferation in the SMC-rich regions of healed rupture sites, providing evidence of further plaque expansion.

Although the current paradigms of coronary atherosclerosis emphasize the importance of SMCs and matrix as contributing factors to plaque growth, the mechanism(s) of arterial narrowing are most likely complex, involving more than an overall increase in plaque burden. Wound contraction as a mechanism of arterial narrowing beyond that of plaque burden alone is supported by a number of animal studies. Fibrin is involved in the progression of luminal narrowing.15 Sequential injury in the rabbit is associated with wound contraction associated with the interaction between SMCs and extensive fibrin deposition.16 These experimental data, along with our study, suggest that selective components of the coagulation cascade may be potential therapeutic targets for the progressive luminal loss associated with episodic ruptures.

In the present study, healed repair sites were characterized by a predominance of SMCs, most likely derived from both migration and proliferation. The relatively low rate of proliferating SMCs in the healing rupture sites is compatible with reports of cell proliferation in native plaques removed by atherectomy.17 18 The increased numbers of proliferating SMCs at healing sites compared with the acute plaque rupture may reflect increased vascularity and wound healing, as suggested by previous topographical studies.18 The relatively weak expression of calponin in the neointimal SMCs suggests that initially the SMCs are proliferating, with few contractile features. Calponin has been demonstrated to be expressed primarily in differentiated SMCs and is involved in the regulation of contraction.19 The complete absence of smoothelin expression within the plaque intima corroborates the lack of fully differentiated contractile SMCs in areas of plaque repair.20

The present study demonstrates an association between diabetes (glucose intolerance) and healed plaque ruptures, as well as an association between obesity and healed plaque ruptures. The fact that the 3 risk factors (dyslipidemia, glucose intolerance, and obesity) would all contribute to an increase in healed plaque ruptures is not unexpected, because of the interrelationship between diabetes, obesity, hypertension, hypertriglyceridemia, and decreased HDL cholesterol. Interestingly, however, we did not find an association between acute plaque ruptures and glucose intolerance. The association between acute ruptures and diabetes may be more difficult to detect because fatal plaque rupture is a single event, as opposed to multiple events in the case of healed plaque ruptures. In a previous study with noncoronary deaths used as controls, we demonstrated an association between diabetes and sudden coronary death with stable plaque in women, although healed ruptures were not investigated in that study.21

Because of a lack of an animal model of plaque rupture, we are restricted to autopsy tissue to explain the morphological changes that occur in unstable plaques. Nevertheless, on the basis of our static observations, the data indicate that at the very least, repeated plaque ruptures that heal are frequent in men who died suddenly. The data further suggest that silent ruptures result in significant increase in plaque burden and negative remodeling. Thus, in many cases, fatal ruptures may represent the final stage of an ongoing process of arterial wound healing.


*    Acknowledgments
 
This work was supported in part by a research grant from the National Institutes of Health (RO1-HL-61799-02) (to Dr Virmani).


*    Footnotes
 
Reprint requests to Renu Virmani, MD, Chairperson, Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army, the Department of the Air Force, or the Department of Defense.

Received August 30, 2000; revision received October 6, 2000; accepted October 16, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363–373.[Free Full Text]
  2. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989;63:114E–120E.[Medline] [Order article via Infotrieve]
  3. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82:265–268.[Abstract/Free Full Text]
  4. Mann JM, Davies MJ. Vulnerable plaque: relation of characteristics to degree of stenosis in human coronary arteries. Circulation. 1996;94:928–931.[Abstract/Free Full Text]
  5. Farb A, Tang A, Burke A, et al. Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701–1709.[Abstract/Free Full Text]
  6. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in patients with coronary disease dying suddenly. N Engl J Med. 1997;336:1276–1282.[Abstract/Free Full Text]
  7. Burke AP, Farb A, Malcom GT, et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921–926.[Abstract/Free Full Text]
  8. Farb A, Burke AP, Tang A, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–1363.[Abstract/Free Full Text]
  9. Tracy R, Mercante D, Moncada A, et al. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol. 1986;85:312–318.[Medline] [Order article via Infotrieve]
  10. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol. 1995;76:24C–33C.[Medline] [Order article via Infotrieve]
  11. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671.[Free Full Text]
  12. Davies MJ. Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation. 1992;85(suppl I):I-19–I-24.
  13. DeWood MA, Leimgruber PP, Shields JP, et al. Thrombosis in acute myocardial infarction and sudden death: angiographic aspects. Cardiovasc Clin. 1987;18:195–211.[Medline] [Order article via Infotrieve]
  14. Arbustini E, Grasso M, Diegoli M, et al. Coronary thrombosis in non-cardiac death. Coron Artery Dis. 1993;4:751–759.[Medline] [Order article via Infotrieve]
  15. Asada Y, Hara S, Tsuneyoshi A, et al. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta. Thromb Haemost. 1998;80:506–511.[Medline] [Order article via Infotrieve]
  16. Courtman DW, Schwartz SM, Hart CE. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: extrinsic pathway inhibition eliminates luminal narrowing. Circ Res. 1998;82:996–1006.[Abstract/Free Full Text]
  17. Marek JM, Koehler C, Aguirre ML, et al. The histologic characteristics of primary and restenotic carotid plaque. J Surg Res. 1998;74:27–33.[Medline] [Order article via Infotrieve]
  18. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 1995;147:668–677.[Abstract]
  19. Menice CB, Hulvershorn J, Adam LP, et al. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem. 1997;272:25157–25161.[Abstract/Free Full Text]
  20. van der Loop FT, Schaart G, Timmer ED, et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol. 1996;134:401–411.[Abstract/Free Full Text]
  21. Burke AP, Farb A, Malcom GT, et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97:2110–2116. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
Y. Qiao, A. Farber, E. Semaan, and J. A. Hamilton
Healing of an Asymptomatic Carotid Plaque Ulceration
Circulation, September 2, 2008; 118(10): e147 - e148.
[Full Text] [PDF]


Home page
JNMHome page
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello
Role of Inflammation in Atherosclerosis
J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. F. Bentzon, C. S. Sondergaard, M. Kassem, and E. Falk
Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice
Circulation, October 30, 2007; 116(18): 2053 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
G. T. Wilson, P. Gopalakrishnan, and T. Tak
Noninvasive Cardiac Imaging with Computed Tomography
Clin. Med. Res., October 1, 2007; 5(3): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J. White, S. J. Duffy, A. S. Walton, J. F. Ng, G. E. Rice, S. Mukherjee, J. A. Shaw, G. L. Jennings, A. M. Dart, and B. A. Kingwell
Matrix metalloproteinase-3 and coronary remodelling: Implications for unstable coronary disease
Cardiovasc Res, September 1, 2007; 75(4): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone
Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Arbustini
Total Erythrocyte Membrane Cholesterol: An Innocent New Marker or an Active Player in Acute Coronary Syndromes?
J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2090 - 2092.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Eur. Heart J., April 1, 2007; 28(7): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Jackson
Defining and Defending Murine Models of Plaque Rupture
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 973 - 977.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk
Plaque Rupture in Humans and Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Jackson, M. R. Bennett, E. A.L. Biessen, J. L. Johnson, and R. Krams
Assessment of Unstable Atherosclerosis in Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 714 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Gross, P. Tilly, D. Hentsch, J.-L. Vonesch, and J.-E. Fabre
Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors
J. Exp. Med., February 19, 2007; 204(2): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
N. N. Boushra and M. Muntazar
Review article: The role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives: [Le role des statines dans la reduction du risque cardiaque perioperatoire : perspectives physiologiques et cliniques].
Can J Anesth, November 1, 2006; 53(11): 1126 - 1147.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. H. Tofler and J. E. Muller
Triggering of Acute Cardiovascular Disease and Potential Preventive Strategies
Circulation, October 24, 2006; 114(17): 1863 - 1872.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Gorenne, M. Kavurma, S. Scott, and M. Bennett
Vascular smooth muscle cell senescence in atherosclerosis
Cardiovasc Res, October 1, 2006; 72(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, M. Valgimigli, S. Vaina, C. van Mieghem, R. J. van Geuns, M. van der Ent, E. Regar, P. de Jaegere, W. van der Giessen, et al.
Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofrequency data analysis
Eur. Heart J., August 2, 2006; 27(16): 1921 - 1927.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. P. Burke, M. Joner, and R. Virmani
IVUS-VH: a predictor of plaque morphology?
Eur. Heart J., August 2, 2006; 27(16): 1889 - 1890.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Crouse III
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Saam, J. Cai, L. Ma, Y.-Q. Cai, M. S. Ferguson, N. L. Polissar, T. S. Hatsukami, and C. Yuan
Comparison of Symptomatic and Asymptomatic Atherosclerotic Carotid Plaque Features with in Vivo MR Imaging.
Radiology, August 1, 2006; 240(2): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
U. Hoffmann, A. J. Pena, R. C. Cury, S. Abbara, M. Ferencik, F. Moselewski, U. Siebert, T. J. Brady, and J. T. Nagurney
Cardiac CT in Emergency Department Patients with Acute Chest Pain.
RadioGraphics, July 1, 2006; 26(4): 963 - 978.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Johnson, A. H. Baker, K. Oka, L. Chan, A. C. Newby, C. L. Jackson, and S. J. George
Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis
Circulation, May 23, 2006; 113(20): 2435 - 2444.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B.-A. Khaw, Y. Tekabe, and L. L. Johnson
Imaging Experimental Atherosclerotic Lesions in ApoE Knockout Mice: Enhanced Targeting with Z2D3-Anti-DTPA Bispecific Antibody and 99mTc-Labeled Negatively Charged Polymers
J. Nucl. Med., May 1, 2006; 47(5): 868 - 876.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Hoffmann, F. Moselewski, K. Nieman, I.-K. Jang, M. Ferencik, A. M. Rahman, R. C. Cury, S. Abbara, H. Joneidi-Jafari, S. Achenbach, et al.
Noninvasive Assessment of Plaque Morphology and Composition in Culprit and Stable Lesions in Acute Coronary Syndrome and Stable Lesions in Stable Angina by Multidetector Computed Tomography
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1655 - 1662.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Falk
Pathogenesis of atherosclerosis.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C7 - C12.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, J. Narula, E. Mahmud, and S. Tsimikas
Imaging vulnerable plaque by ultrasound.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C32 - C39.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Chu, C. Yuan, N. Takaya, J. R. Shewchuk, A. W. Clowes, and T. S. Hatsukami
Serial High-Spatial-Resolution, Multisequence Magnetic Resonance Imaging Studies Identify Fibrous Cap Rupture and Penetrating Ulcer Into Carotid Atherosclerotic Plaque
Circulation, March 28, 2006; 113(12): e660 - e661.
[Full Text] [PDF]


Home page
CirculationHome page
A. Schmermund, S. Achenbach, T. Budde, Y. Buziashvili, A. Forster, G. Friedrich, M. Henein, G. Kerkhoff, F. Knollmann, V. Kukharchuk, et al.
Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial
Circulation, January 24, 2006; 113(3): 427 - 437.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, E. P. Mc Fadden, M. Valgimigli, J. Aoki, P. de Feyter, and P. W. Serruys
In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2038 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page